# CardioFlow to acquire MicroPort Cardiac Rhythm Management

CardioFlow (02160) announced a merger agreement to acquire MicroPort Cardiac Rhythm Management (a subsidiary of MicroPort Scientific) for a valuation of $680 million. The acquisition will be effected through a merger, with CardioFlow issuing new shares as consideration.

- Type: Acquisition
- Announced: 2025-09-29
- Where: China
- Value: $680.0M
- Status: announced
- Products: cardiac rhythm management devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [MicroPort Scientific Corporation](https://endata.com/companies/20849.md) (partner)
- [CardioFlow](https://endata.com/companies/87417.md) (acquirer)
- [MicroPort Cardiac Rhythm Management](https://endata.com/companies/87418.md) (target)

## Sources

- [beta.zhitongcaijing.com](http://beta.zhitongcaijing.com/content/detail/1350961.html), 2025-09-29: "本公司将以合并方式收购目标公司，合并附属公司及目标公司将于生效时间合并并作为一家公司存续"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.